Kazia Therapeutics (KZIA) Depreciation and Depletion (2009)

Kazia Therapeutics (KZIA) posted Depreciation and Depletion of -$110000.0 for Q4 2009.

Kazia Therapeutics (KZIA) Depreciation and Depletion (2009) Analysis & Trends

Kazia Therapeutics' Depreciation and Depletion history runs 1 years deep, the most recent figure standing at -$110000.0 for Q4 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Depreciation and Depletion (Qtr)
1	Oculis Holding AG	66,290.43 Bn	66,290.15 Bn	-	196,658.72
2	Nanobiotix	1,914.07 Bn	1,914.01 Bn	-	-
3	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-	-
4	BeOne Medicines	467.97 Bn	463.18 Bn	1.35 Bn	39.39 Mn
5	Vertex Pharmaceuticals	122.73 Bn	115.48 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	70.42 Bn	61.67 Bn	3.31 Bn	-
7	Belite Bio	62.82 Bn	62.82 Bn	-	-
8	Argenx Se	56.00 Bn	50.82 Bn	1.41 Bn	-
9	Alnylam Pharmaceuticals	37.51 Bn	34.50 Bn	959.66 Mn	-
10	Kazia Therapeutics	19.25 Bn	19.25 Bn	-	-

Download Data

Date	Value
Dec 31, 2009	-110,000.00
Dec 31, 2009	-110,000.00